Furthermore, Huang et al. [48] discovered that elevated levels of HOXC6 in gliomas showed a positive association with increased stromal and immune scores, as well as elevated expression of various immune checkpoint genes (such as PD-L1 and CTLA-4). Here, CTLA4 is linked to central nervous system cancer.